Prostate Cancer Diagnosis Pathway: 2024 Update

Anwar Padhani

A. Padhani

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

UNC Lineberger Comprehensive Cancer Center

N. Robertson

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

Bladder Cancer Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Cancer Screening Molecular Tools

Fengting Yan

Aggressive Variant Prostate Cancer: Definition, Diagnosis, Treatment…

Ana Aparicio

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

Whole-Body MRI: Past, Present, and Future

Houston Methodist

N. Gupta

AUA Advanced Prostate Cancer Guidelines: 2023 Update

Robert Dreicer

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

ASCO® 2024 Prostate Cancer Take-Home Messages

2024 ASCO® Annual Meeting Insights Hub

E. Efstathiou

Precision Therapies for Prostate Cancer

University of Miami Sylvester Comprehensive Cancer Center

M. Bilusic

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

Treatment (De)Intensification in RCC

International Urology Cancer Summit - IUCS

S. Kumar Pal

Advances in Prostate Cancer Surgery

Penn Medicine Abramson Cancer Center

B. Schurhamer, T. Guzzo

Review of Bladder Cancer Updates From ESMO 2024

The View on GU | with Lalani & Wallis

A. A. Lalani, C. Wallis

ASCO® 2023 Insights: "PSMAddition - A Phase 3 Trial to Compare Treat…

Insights from 2023 ASCO® Annual Meeting

S. Tagawa

Visible vs. Invisible Cancers - The Genomics and Natural History

Laurence Klotz